Back to Search
LEIF ELLISEN, MD PHD
MD PHD
Medical Oncology Physician
NPI: 1225028533IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
79659(MA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
79659(MA)
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1992
Research & Publications (20)
Growth control under stress: mTOR regulation through the REDD1-TSC pathway.
PMID 16258273·Cell Cycle·2005
6-review
Regulation of gene expression by WT1 in development and tumorigenesis.
PMID 12215008·Int J Hematol·2002
6-review
REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.
PMID 12453409·Mol Cell·2002
7-preclinical
Cascades of transcriptional induction during human lymphocyte activation.
PMID 11432721·Eur J Cell Biol·2001
8-other
The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells.
PMID 11296223·EMBO J·2001
8-other
Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.
PMID 19240170·Clin Cancer Res·2009
8-other
FOXO-regulated transcription restricts overgrowth of Tsc mutant organs.
PMID 18299344·J Cell Biol·2008
7-preclinical
Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells.
PMID 18292212·Stem Cells·2008
7-preclinical
Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling.
PMID 18198340·Genes Dev·2008
7-preclinical
The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.
PMID 17446929·J Clin Invest·2007
8-other
Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1.
PMID 17074751·J Biol Chem·2006
7-preclinical
Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
PMID 17018588·Cancer Res·2006
7-preclinical
p63 regulates an adhesion programme and cell survival in epithelial cells.
PMID 16715076·Nat Cell Biol·2006
8-other
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.
PMID 16413471·Cancer Cell·2006
8-other
Regulation of mTOR and cell growth in response to energy stress by REDD1.
PMID 15988001·Mol Cell Biol·2005
7-preclinical
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.
PMID 15545625·Genes Dev·2004
7-preclinical
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.
PMID 12506169·J Clin Oncol·2003
3-trial
A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1.
PMID 11278547·J Biol Chem·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 FRUIT ST, GRJ 904
BOSTON, MA 02114 - Phone
- (617) 724-1399
Quick Facts
- NPI
- 1225028533
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile